Komori
Governance4502Takeda Pharmaceutical Company LimitedPharmaceuticals

Independent Officer Notification Form

The Independent Officer Notification Form was updated because a proposal to elect outside directors will be submitted to the Annual General Meeting of Shareholders. 8 outside directors have been notified as Independent Officers, 3 of whom are scheduled to be newly appointed.

Worth reading
63In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
8
People (Independent Officers and outside directors)
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Number of independent officers8Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Committee2
Nomination CommitteeCompensation Committee. Proportion of outside members: 非開示
Changes this time

Submitted because a proposal to elect outside officers will be submitted to the Annual General Meeting of Shareholders. Of the 8 outside directors, Paul Stoffels (ポール・ストフェルス), Bruce Broussard (ブルース・ブルサード) and Kimura Koichiro (木村浩一郎) are scheduled to be newly appointed.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of independent officers8 independent officers
CommitteeNomination Committee, Compensation Committee. Proportion of outside members: Not disclosed
Changes this timeSubmitted because a proposal to elect outside officers will be submitted to the Annual General Meeting of Shareholders. Of the 8 outside directors, Paul Stoffels (ポール・ストフェルス), Bruce Broussard (ブルース・ブルサード) and Kimura Koichiro (木村浩一郎) are scheduled to be newly appointed.
Items this document does not state (4)
Number of directorsPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because proposals for the election of outside officers will be submitted to the Annual General Meeting of Shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | Takeda Pharmaceutical Company Limited (4502) timely disclosure | Komori